Menu

An expert resource for medical professionals
Provided FREE as a service to women’s health

The Alliance for
Global Women’s Medicine
A worldwide fellowship of health professionals working together to
promote, advocate for and enhance the Welfare of Women everywhere

An Educational Platform for FIGO

The Global Library of Women’s Medicine
Clinical guidance and resourses

A vast range of expert online resources. A FREE and entirely CHARITABLE site to support women’s healthcare professionals

The Global Academy of Women’s Medicine
Teaching, research and Diplomates Association

This chapter should be cited as follows:
Labbok, M, Glob. libr. women's med.,
(ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10397
This chapter was last updated:
November 2008

Breastfeeding, Fertility, and Family Planning

Authors

INTRODUCTION

Breastfeeding is associated with many maternal and child health benefits,1, 2, 3 including a delay in fertility return postpartum. This has been recognized for centuries; medical literature from Aristotle to the Renaissance, and, occasionally, thereafter, noted that women who suckle are less likely to become pregnant. This physiological response was forgotten or disbelieved in scientific circles of the mid 20th century as the use of commercial infant formula displaced breastfeeding in industrialized settings, and family planning methods became more widely available. However, recent scientific evidence, compiled both by social and biomedical sciences, demonstrating the population level impact of breastfeeding on fertility and the biologic basis of lactational infertility, has reinitiated interest in breastfeeding and the mechanisms related to lactational infertility. If we allow breastfeeding to deteriorate further, the increase in fertility in settings with limited family planning use would be significant, and very difficult to remedy.4, 5

Today, breastfeeding is being rediscovered and has become the normative initial infant feeding behavior; however, the optimal patterns of breastfeeding that are also associated with fertility reduction are not as yet the norm in many industrialized settings. Optimal breastfeeding for child health is defined by the World Health Organization (WHO) as six months exclusive breastfeeding6 followed by continued breastfeeding with age-appropriate complementary feeding for up to two years or longer.7 The Healthy People 2010 goals for the United States include at least 75% initiation, with 50% continuation to six months and 25% to one year, and exclusive breastfeeding among 40% for three months and 17% for six months. Data from the US Centers for Disease Control and Prevention8 and National Center for Health Statistics now reflect achievement of the initiation goal. Although rates fall off over time, this still means that a majority of postpartum women will be introducing some form of contraception during breastfeeding. However, there remains rapid fall off in continuation and exclusivity (see Table 1). Therefore, for optimal maternal and child health outcomes, physicians must increasingly have the knowledge and skills to support both optimal breastfeeding and appropriate family planning introduction during lactation.

Table 1: Breastfeeding in the United States and globally9

 

Initiation

6 months

12 months

Exclusive 3 months

Exclusive 6 months

US

74.2 ± 1.2

43.1 ± 1.3

21.4 ± 1.1

31.5 ± 1.3*

11.9 ± 0.9*

Developing settings

> 95

-

40 ^

-

38**

World

> 90

-

39 ^

-

38 **

* percent exclusive for the full duration; **percent exclusive in a sample of 0-6 months; ^ at 20-23 months of age

Good clinical practice will depend on achieving knowledge and skills to address issues associated with breastfeeding and fertility, including basic anatomy and physiology as they apply to both lactation and the fertility aspects of breastfeeding, and the proper counseling and timing of the provision of contraceptives. The practitioner may also need the knowledge and skills to support conception during breastfeeding, when warranted.

RESEARCH DESIGN ISSUES IN THE STUDY OF BREASTFEEDING AND FERTILITY

There are research design and analysis issues that have increased the publication of apparently conflicting findings in published studies on breastfeeding and fertility.

Definitions of Characteristics under Study

The term breastfeeding is used to describe a wide variety of behaviors and physiologic states in both mothers and the children. A commonly used definition in the 1960s and 1970s was that of the commercial infant formula industry, which defined breastfeeding in relation to a formula norm. Breastfeeding was generally defined by a ‘yes’ or ‘no’ response, with limited consideration of pattern or exclusivity. Industry interests are to sell product, so the term exclusive breastfeeding was used when breastfeeding with no formula use. However, this definition allowed for other food and drink to be given, and still be defined as ‘exclusive’ breastfeeding. In the past, the US Women, Infants and Children program (WIC) defined a mother-infant pair as breastfeeding if they ever breastfed at all; others have used definitions that describe varying time periods. These definitions, which reveal little about infant nutrition or about maternal physiology, continue to be used by some researchers, creating apparently conflicting findings for the casual reader of the literature.

Many journals now accept definitions that may be more reflective of the maternal and infant behavior and its potential impact on their physiology.10 This definitional schema:

  • defines the feeding pattern during a single period in time, perhaps a 24-hour recall
  • defines only breastfeeding and records, but does not define, other forms of feeding
  • demands attention to both the maternal and the child's involvement
  • differentiates breastfeeding from human milk feeding.
  • encourages additional description of the behavior beyond the basic terms in Table 2

The schema also suggests that researchers and program planners note frequency, timing and length of intervals, age of the child, use of expressed milk, how other milks are given, whether pacifier use allowed, and, where applicable, the type, timing, and amount of other feeds. If used, such a schema would allow differentiating between the specific behaviors and the physiologic consequences. Only by including these issues can one assess the patterns which impact on physiology in addition to nutritional outcomes, very important in light of the differential in the physiologic responses to different modes of milk expression and direct suckling.11

A widely used set of definitions was developed subsequently by the WHO, modified from that presented above, but simplified such that they are appropriate to describe infant nutritional intake, but are less relevant for the understanding of maternal and child physiology.12 This newer set of definitions does not take into account the impact on maternal physiology and potential milk maintenance, the potential differences in behaviors within the definitions used, nor the differences between direct breastfeeding and indirect human milk feeding, in terms of immunologic and other factors. These two sets of definitions are compared in Table 2.

Table 2. Physiology-based and infant nutrition-based definitions of breastfeeding

Term

Physiologically based definitional schema*

Infant intake based definition of World Health Organization

Breastfeeding

The child directly ingests breastmilk from the mother's breast.

The child has received breastmilk (direct from the breast or expressed).

Breastmilk feeding

Milk is expressed and given to the infant.

Not defined.

Exclusive breastfeeding

Feeding is exclusively from the breast. No other liquid or solid from any other source enters the infant's mouth.

The infant has received only breastmilk from his/her mother or a wet nurse, or expressed breastmilk, and no other liquids or solids with the exception of drops or syrups consisting of vitamins, mineral supplements, or medicines.

Almost exclusive

Allows occasional other tastes of liquids, traditional foods, vitamins, medicines, etc.

Not defined.

Predominant

Not defined.

The infant's predominant source of nourishment has been breastmilk. However, the infant may also have received water and water-based drinks (e.g. sweetened and flavored water, teas, infusions); fruit juice; oral rehydration salts solution; drop and syrup forms of vitamins, minerals and medicines; and ritual fluids (in limited quantities). With the exception of fruit juice and sugar-water, no food-based fluid is allowed under this definition.

Full breastfeeding

Includes exclusive and almost exclusive, as already defined.

Includes exclusive breastfeeding and predominant breastfeeding, as defined above.

Full breastmilk feeding

Receives expressed breastmilk, in addition to breastfeeding.

Not defined.

Partial

Mixed feeding designated at high, medium or low. Methods for classification suggested include percentage of calories from breastfeeding, percentage of feeds that are breastfeeds, among others. Any feeding of expressed breastmilk falls under this category.

Not defined.

Complementary feeding

Other food or milk given in addition to breastmilk, thus displacing breastmilk intake.

The child has received both breastmilk and solid (or semisolid) food.

Token

Minimal, occasional breastfeeds (for comfort or with less than 10% of the nutrition provided thereby).

Not defined.

*Calls for age of child; feeding frequency and intervals; use of bottle, cup, spoon, pacifier; and feeding of expressed milk be recorded for each definition where available.

The immense variability in lactation and breastfeeding behaviors necessitates large samples sizes to fully explore the impact of the differences. However, the relatively short durations of lactation, and the prevalence and use of contraceptives that mask or interfere with physiologic changes have limited the number of such studies completed in industrialized countries. Therefore, much of what we understand is derived from small clinical studies, some of which have not been able to control for even the most important variables, such as sucking stimulus or age of infant. Other studies have used quasi-experimental or epidemiological methods, with intervention and assessment at the population level rather than the individual level.

Sampling Frame and Sample Size

Immense differences in lactational behaviors indicate that large samples would be necessary to control for this variable alone. However, the relatively short durations of lactation, and the prevalence and use of contraceptives that mask or interfere with physiologic changes, limit study in industrialized countries. Therefore, much of what we understand is derived from limited clinical studies, some of which have little control over sucking stimulus or age of infant or that information is inferred from larger prospective studies with limited neuroendocrinologic elements.

Selection Bias in Selection of Cases and Controls

Breastfeeding patterns are skewed, with more breastfeeding occurring among those earlier postpartum. With or without breastfeeding, normal maternal physiology undergoes changes postpartum. Therefore, the choice of infant age group/time postpartum studied can significantly influence physiologic outcomes. This is further complicated by the difficulty in random assignment of these breastfeeding and complementary feeding behaviors. It is not ethically possible, nor probable that groups of women would agree, to be assigned to breastfeed or not breastfeed. It is even more unlikely that infants will cooperate with the timing of their hunger or the intensity of their suck at any particular time. This may lead to confounding, associated with the factors that may influence self-selection into one pattern of feeding or another.

Recall Bias

Many studies include data from mothers whose children have long since stopped breastfeeding. Their recall may be biased by subsequent child health events or by the breastfeeding experience of subsequent pregnancies. CDC recently explored recall and found many definitional flaws and inconsistencies.

Analytic Plan and Techniques Used

Proper selection of statistical approach is vital. There are many textbooks designed for the clinician or occasional researcher. The analysis plan should be designed before data are gathered, because it may dictate to some extent the sample frame and size. However, it remains important to reassess the plan after data are collected. The data set may have insufficient numbers in proposed subgroups due to limited variability within the sample, or may not reflect other assumptions used in planning. For example, if all women in the sample breastfeed for about the same length of time, there will be insufficient variability in the data set to assess the biologic impacts of varying durations of breastfeeding.

Selective Presentation of Findings due to Journal Space Limits

Because journals frequently limit the length of articles, important facts in the interpretation of the findings may be inadvertently omitted. Also, negative results are rarely accepted for publication.

Misinterpretation or Confused Conclusions, and Conviction-Based Bias in Presentation

In statistics, terms such as association or determinant may be misinterpreted as meaning causation. Two things may be statistically significantly associated but have no biologically meaningful relationship. Although we like to think that scientists are unbiased, each works from personal understanding of the issue in question. This may affect how the hypothesis is stated and tested, and which data are presented. If findings do not support the author's hypothesis or do not achieve statistical significance, it is often difficult to find the energy—or the journal willing—to publish it. Finally, discussion and conclusion sections of papers may include statements that overstate or reinterpret what the findings show.

These difficulties compound the problems of data collection and analysis in this already complex area of study.

PHYSIOLOGY OF LACTATIONAL INFERTILITY

The anatomy of the breast and the hypothalamic-pituitary axis for release of prolactin and the production of breast milk may be found elsewhere in this text. These same structures are integral to the mammary-hypothalamic-pituitary-ovarian axis that mediates lactational infertility. The current understanding of the physiology of this feedback system is derived from studies of the different systems under conditions of lactation and nonlactation. Because of the difficulties in studying these phenomena, as previously outlined, this section summarizes current understanding and presents also a summary of studies that confirm the underlying conclusions presented here.

Summary

Suckling at the breast, especially with active stimulation of the nipple and areola and the structures that underlie them, stimulates an inhibition of the pulsatile release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn, disorganizes the pulsatility and levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The result of the disruption of the levels of LH, and the sometimes reduced levels of FSH, is suppression of the development and release of a viable follicle and ovum. Over time, as erratic pulsatility begins, there will be some ovarian follicular development with increases in inhibin B and estradiol. When this occurs, there can be a paradoxical re-suppression of fertility, rather than the stimulation of ovulation seen in non-breastfeeding women13 (see Fig. 1). With increasingly normal pulsatility, associated with decreases in the suckling stimulus, a resumption of apparently normal follicle growth occurs associated with a normal increase in estradiol. However, this is often associated with the formation of an inadequate corpus luteum. Eventually, there is a return to normal ovulatory menstrual cycles.14

Oxytocin release from the posterior pituitary, which stimulates the let-down reflex, allowing milk to flow through the capillary-like mammary tubules, has not as yet been linked to suppression of fertility; however, its establishment is necessary for successful lactation, and, as such, is a necessary part of the lactational infertility.15 Plasma prolactin levels that are associated with milk production in the early days postpartum are less associated with milk production as time progresses,16 and these levels would seem to have a limited role in the feedback system that suppresses ovulation. In addition, maternal nutritional status is much less important than the pattern of infant breastfeeding; however, the maternal nutritional status may impact the feeding pattern. While much of the underlying physiology remains to be elucidated, the basic parameters of this feedback system may be seen in Fig. 1.

Fig. 1. Mammary-hypothalamic-pituitary-ovarian feedback system: suppression of fertility and menses related to breastfeeding.

Discussion of Research

A recent symposium attempted to bring together scientists to discuss the current understanding and gaps in the knowledge concerning the physiologic basis of lactational infertility. Based on exploration of published and unpublished literature, three stages were identified:17 early postpartum lactational amenorrhea, continued lactational amenorrhea, and menses return.

The early postpartum period, in this context, is the 6–8 weeks postpartum during which the inhibitory mechanisms of pregnancy continue to produce an impact, with diminished pituitary response to the hypothalamic release of GnRH. This is possibly due to reduced activity of the GnRH pulse generator; however, in the first month postpartum, there is no LH response to a GnRH bolus. Studies of LH activity during this same period have yielded variable findings, indicating that there may be individual or behavior-based variation. Another study shows that the LH pulse frequency is not significantly different from that found in the early follicular phase; the peak levels, however, are significantly reduced.18 By the second postpartum month, LH response to a GnRH bolus may be seen, indicating a shift in the underlying mechanisms.19 This would imply decreased end-organ receptivity, in this case the pituitary. Opiates do not seem to mediate this shift in humans as they do in some nonhuman animal models.20 The timing of this shift may be dictated by intensity and pattern of feeding or by individual physiologic differences.

Those factors that influence the duration of continuing lactational amenorrhea, in relation to the duration of lactation, are not fully understood. At the same time, ongoing diminished GnRH and pituitary responsiveness continue in relationship to the intensity of the suckling stimulus. However, quantifying this phenomenon is difficult. Other mechanisms are thought to contribute, creating a complex of sometimes-conflicting feedback loops. These include enhanced or paradoxical negative feedback of ovarian secretions on the hypothalamic-pituitary axis; failure of positive feedback actions, lack of stimulation of the hypothalamus; decreased number or function of GnRH receptors; altered biologic activity of the hormones of ovulation; and a variable role of prolactin. It was concluded that there is a possibility of redundancy in these mechanisms.15

Attempts to elucidate the role of prolactin have found little direct involvement in the suppression of fertility. One important study included 20 women, with 24-hour blood sampling every 10 minutes, at either four or eight weeks postpartum, at either time of introduction of supplements, at first menses while continuing breastfeeding, and in the follicular phase of the first cycle after weaning. Results included that the pattern of prolactin levels was responsive to breastfeeding pattern, but that there was no relationship between the plasma concentrations, day or night, and the duration of amenorrhea. There was, however, a strong and statistically significant correlation between the timing of introduction of food or liquids and the duration of amenorrhea.21, 22 Feeding the infant any foods in addition to breastfeeding prior to six months of age is associated with about a 4–6 fold increase in the risk of menses return prior to six months.23 Another study of 10 women in Chile found that women who returned to fertility earlier exhibited a smaller prolactin response to suckling as early as the first month postpartum than was found among those with a delayed return of fertility.24 Although prolactin levels clearly are responsive to suckling, and there is an association of prolactin response and earlier return of menses, the pattern of prolactin release is not predictive of fertility return for the individual.

Another long-held hypothesis was that maternal fat stores dictated the duration of lactational infertility. To investigate the extent to which better maternal nutrition is associated with a reduction in the duration of lactational amenorrhea, data on 339 mother-infant pairs were analyzed.25 Maternal triceps skinfold was negatively associated with the length of amenorrhea; once controlled for infant feeding pattern, the effect was small; only a 0.5-month difference was seen when the 25th and 75th percentiles were compared. Improved maternal nutritional status by supplementation was not associated with change in length of amenorrhea if controlled for infant supplemental feeding. In another study, the effect of body mass index on lactational amenorrhea became nonsignificant when controlling for lack of formula feeds, maternal age, and socioeconomic status.26These studies suggest that infant, not maternal, supplementation influences the duration of lactational amenorrhea, and that maternal nutritional status has modest influence. In a recent review of the physiology of lactation, Neville raises the possibility that another hormone associated with nutritional status, such as the appetite-suppressing hormone leptin, may play a role.27 It may be that the physiology of the negative association of maternal overweight with breastfeeding initiation and duration28 has an influence on these studies, creating a bias in which mothers enter the cohort. Although the impact of nutritional status on lactational amenorrhea is less significant than earlier believed, the factors that mediate this association remain to be elucidated.

The return of menses during lactation is highly variable, among individuals and among cultural groupings.29, 30 There are many behavioral and physiologic parameters that may have some impact on the timing of the return of fertility during lactation. Clearly, the sucking stimulus is a major variable and accounts for much of the variation seen. Frequency, with recovery time during the interval between feeds, intensity of the child's suckling, and hence breast stimulation, and the sensitivity of the nipple and areola of the breast, may all play a role. There appears to be increased pituitary responsiveness to GnRH over time; however, the presumed mediation by β-endorphins or opiates, has not been substantiated in humans. Whether it is dictated by individual variation in neuroendocrine response to the stimuli, the variation in bioactivity of specific hormones and end organ, including ovarian, response to the changes remains to be assessed.

Fertility does not necessarily return immediately with the return of regular vaginal bleeds. The first cycles during breastfeeding frequently are associated with abnormal ovulatory activity and luteal phase defects. Studies have found, on average, a gradual return to normality over the first three cycles. An analysis of survey data found that, in areas where breastfeeding is practiced physiologically, that is, frequently day and night with little to no supplementation given, the continuation of breastfeeding after menses return is associated with significant continuing delay in fertility. In this study, for each additional month of breastfeeding after menses return, there is about 7.4% reduction in risk of conception.31 This is thought to be primarily due to ongoing luteal phase defects.32

Differentiation of the first hormonally induced bleed from continued lochia or perceived end-of-puerperium bleeding episodes may present an issue for some women, especially those interested in charting their cycles or predicting the next bleed. A multicenter multinational study of the return of a hormonally induced bleed, retrospectively defined as a bleed followed by another bleed within 21–70 days found that the duration of lochia varied significantly. The conclusion was that among intensively breastfeeding women, about 11% experienced such a bleed in the first two months postpartum.33

The suckling at the breast is the major stimulus of the feedback; however, the specific attributes of the suckling that contribute to the suppression of fertility are not fully elucidated. Clearly, frequency of the suckling episodes is vital. In the very early postpartum stage, suckling of 10–12 times a day appears the minimum number necessary to establish full lactation and fertility suppression. During the second stage, frequency may be reduced, but increasing intervals between feeds and initiation of or increase in supplementation are associated with hastened return of both ovulation and return of menses.31, 34 After menses, or regular bleeds, recurs, frequent suckling continues to be associated with decreased fertility. Other parameters of the suck stimulus have been harder to study. In an effort to assess the impact of sucking intensity, a pressure transducer was attached to the nipple of exclusively breastfeeding women (n = 62) at two and five months postpartum. Although the efficiency and duration of the suckling, per se, were not correlated with duration of amenorrhea, the time at the breast in non-suckling pauses was positively associated with a delay in menses return.35 This may indicate that sensory stimulation other than suckling alone may have a vital role in the feedback to the hypothalamus. Possible areas for further exploration include the importance of olfaction in early mother-infant bonding36 and cosleeping. These areas remain to be studied in relation to the duration of lactational infertility, and the physiologic impact of behaviors and sensory stimuli.

BREASTFEEDING AND FAMILY PLANNING

Contraceptive Use During Lactation

Studies of maternal nutritional recovery postpartum and of outcomes of subsequent pregnancies have shown that spacing of births is necessary for improved outcomes. Child spacing of about 28 months is suggested as healthiest for pregnancy outcomes in a US-based population.37, 38 In developing country settings, spacing of this length or longer is recommended.39 Although breastfeeding alone can result in spacing of this duration, the individual woman is cautioned not to rely on breastfeeding alone if she wishes to achieve this goal. Therefore, the introduction and use of family planning during breastfeeding are important health interventions.

The choice of method should be the woman's, based on complete information on which to make an informed choice. Counseling is generally necessary to ensure that this fully informed choice can occur. Generally, contraceptive technology texts emphasize efficacy as the major criterion for method selection. In fact, women's choices are generally based on various other factors, including personal experience, a desire to delay or permanently cease childbearing, lifestyle, and religious influences. She might also be influenced by the other health impacts of the method on her or her child, in addition to those directly associated with breastfeeding and contraceptive efficacy. Some of these are presented in Table 3.

Table 3. Summary of the non-contraceptive health issues associated with the use of contraceptive methods

 

Milk quantity and infant growth

Passage to infant

Maternal health*

Condom

Reduced HIV and other sexually transmitted disease infection rates.

Intrauterine device—nonsteroidal

Some reports of increase in milk quantity.40

May be associated with increased blood loss.

Combined oral contraceptives

May decrease milk quantity, even in low-dose preparations.

Infant receives about 0.1–0.2% of maternal dose.41

May lower levels of some vitamins and minerals and may have circulatory effects, particularly important immediately postpartum.

Progestin-only oral contraceptives (POCs)

Positive effects in studies, anecdotal negative effects in clinical practice. Perhaps dependent on estrogenicity or related behaviors and stresses.

Infant probably receives about 0.1–0.2% of maternal dose.

Assumed to be less than estrogenic formulations.

Depo-Provera (depot medroxyprogesterone acetate, DMPA).

Positive. Few studies on use prior to 4–6 weeks postpartum.

MPA passes at plasma levels into the breastmilk, however uptake from the circulatory system is limited.

Assumed to be less than estrogenic formulations.

Norplant

No negative effect. Slightly negative when given before six weeks.42

Infant receives about 5–15% of maternal dose.43

Lowest levels, therefore assumed to have least effect.

Vaginal ring with progesterone

No negative impact on breastfeeding or growth.44

Lowest levels, therefore assumed to have least effect.


*Hormonal methods may have long-term health benefits for women including decreased rates of reproductive tract cancers; methods that reduce menstrual blood loss would contribute to anemia reduction. (Hatcher R, Rhinehart W, Blackburn R et al: The Essentials of Contraceptive Technology pp 4–19. Baltimore: Johns Hopkins School of Public Health, Population Information Program, 1997.)

Table 4 presents the method options categorized by potential impact on breastfeeding, not on efficacy of the method or the other issues that may be of interest to the individual patient. (The American College of Obstetrics and Gynecology issued guidelines on aspects of breastfeeding. The guidelines support this table while allowing earlier initiation of hormonal methods when appropriate.)

Table 4. Family planning considerations for the breastfeeding woman

Method

Failure rates* ‘common’ use/’perfect’ use

Breastfeeding and reproductive health considerations, advantages, disadvantages

First choice: Nonhormonal methods

LAM

2/0.5

Supports optimal breastfeeding.

Condoms

15/2

Decreases transmission of HIV and other infectious diseases that may pass to the child through breastfeeding.

Diaphragm with spermicide

16/6

Size requirement may change postpartum and refitting should occur at after 6–8 weeks.

May provide reduce transmission of some infections.

Spermicides

29/18

May provide reduce transmission of some infections.

May provide needed lubrication.

Intrauterine devices (IUDs) (nonhormonal, with copper)
(Hormone
(progestin) containing IUDs)

0.8/0.6


0.2/0.2

Insertion should occur within four days or after four weeks postpartum.

No effect of IUD or copper on breastfeeding.

Reports of reduced perceptions of discomfort if inserted while mother is still lactating.

Natural family planning (periodic abstinence)

20/3–5

May require special training for previous users since signs and symptoms use in the methods may differ during lactation.

Some methods may result in prolonged periods of abstinence during lactation.

Vasectomy

0.15/0.1

No impact on any maternal or infant health parameters.

Tubal ligation

0.5/0.5

May involve a period of separation.

May involve anesthesia, analgesia, but rarely necessitates interruption of lactation.

Second choice: progestin-only methods

Mini-pill

8/0.3

Limited research on use before six weeks postpartum in lactating women.

Injectables

3/0.3

Possible maternal health effects of progestin use very early postpartum.

Implants

0.05/0.05

World Health Organization recommends delay for at least six weeks postpartum.

Vaginal ring with progesterone during breastfeeding

8/0.3

World Health Organization recommends delay for at least six weeks postpartum.

Third choice: methods containing estrogens

Combined oral contraceptives/injectables

3–8/0.3

Estrogenic component may reduce milk supply, change electrolyte composition.

Combined Injectables

0.3/0.3

World Health Organization recommends delay for at least six months postpartum, or until exclusive breastfeeding is ended.

LAM, lactational amenorrhea method.
*Most pregnancy, or failure, rates as presented are from life-table analyses in studies of women who are not breastfeeding, except as indicated. These rates would be expected to be lower when used during breastfeeding due the additive impact of to its fertility suppressive effects. Pregnancy rates presented are based on studies of use during lactation. (Modified from Hatcher R, Trussell J, Nelson A, et al: Contraceptive Technology, pp 407-409, 759. Ardent Media, Inc. 2007.45)

Nonhormonal methods are considered the first choice because they have no direct impact on breastfeeding. The lactational amenorrhea method (LAM), described later in this chapter, may be used as in introduction to other method selection, or as the primary method in the early months. In addition to LAM, the choices include physical, chemical, and temporal barriers, as well as male and female sterilization.

Second choice is the progestin-only methods that have been extensively tested and found safe in later breastfeeding.46 In the last decade, possible association with maternal bone loss became an issue. A prospective study of levonorgestrel (Norplant), progesterone vaginal rings, and CuT380 intrauterine devices (IUDs) found no difference in bone status among the three groups at months 1 and 12 postpartum, and at six and 12 months after cessation of lactation.47 There are many studies of vaginal rings, a method not as yet approved for use in the United States, that show this to be a safe and efficacious method for lactating women; however, there remain issues of user satisfaction.

The timing of introduction of progestin-only methods continues to be debated. There is little in the literature on the use of these methods during the first 4–6 weeks postpartum among fully breastfeeding women. Assessment of the studies available, clinical reports, and preliminary guidance from the WHO would encourage caution, recommending delay of use for at least six weeks postpartum, and calling for further research concerning this specific situation.

The estrogenic methods, despite their higher efficacy, are considered third choice because of their known negative effect on milk production. Other concerns, such as changes in micronutrients, including iron, calcium, copper and phosphorus, seem unfounded.48, 49 Consideration has been given to whether a woman should switch from the less efficacious progesterone-only methods to the estrogenic methods at some point during lactation. An opinion poll of 20 providers considered to be expert in the field concluded that there is no reason to switch during early lactation but that there is no problem with doing so after six months postpartum.50

Breastfeeding can significantly reduce menstrual loss and fertility, but cannot alone provide reliable adequate child spacing for most women. Although further research is needed to understand all the neuroendocrine mechanisms underlying lactational infertility fully, clinical studies have outlined the parameters under which breastfeeding can be reliable. LAM should be considered an option in the complete picture of informed family planning choice for the lactating woman. This issue is addressed regularly by the Academy of Breastfeeding Medicine Protocol #13.51

Family Planning Based on the Physiology of Lactation

There has been interest in building on lactational infertility to create a reliable, efficacious form of family planning for more than 30 years. In the 1970s, researchers began to publish studies showing that under clinical conditions of full breastfeeding and amenorrhea, fertility would be a rare event.34 At the same time, Tyson and others pursued the pituitary-gonadotrophin route, assessing the impact of thyrotropin-releasing hormone (TRH) and other related hormonal releasing hormones on fertility.34, 52, 53 More recently, it has been suggested that GnRH agonists might enhance the impact and duration of lactational infertility.54 These approaches that enhance or suppress the hormonal feedback system have been associated with acceptable side effects. Although there is a high correlation of the timing postpartum of fertility return with previous breastfeeding experience when measured in a population of women, this is not a reliable indicator for the individual.

Stimulated by these early publications, researchers began to explore the relationship between breastfeeding patterns, menses return, and fertility suppression to see whether a noninvasive approach based on an improved understanding of the physiology might be possible. In 1988, the research findings of several centers around the world were shared at a meeting at the Rockefeller Bellagio Conference Center, and the scientists agreed that three criteria (i.e. full breastfeeding, amenorrhea, first six months postpartum) would be sufficient to serve as a method. These findings became known as the Bellagio Consensus.55 A few months later, this approach was presented to a group of family planning service providers at a meeting at Georgetown, in the District of Columbia, and LAM was developed as a clinical algorithm, and guidelines were prepared.56

LAM is a postpartum introductory method that includes three criteria for defining the period of lowest pregnancy risk and then advises immediate commencement of another method that complements the effects of breastfeeding thereafter. Clinically, the mother would be asked whether her menses have resumed, whether she is no longer fully or nearly fully breastfeeding, and whether the infant is six months of age or older. If the answer to any of these is affirmative, she is advised to begin another method of family planning, preferably one that will have no negative effects on lactation (Fig. 2). Counseling includes timely switch to another method compatible with lactation, and the encouragement of healthy birth spacing of about 2.5–3 years, allowing for maternal recovery postpartum and postlactation before another pregnancy commences.

Fig. 2. Lactational amenorrhea method

Because this method is based on behavior, there is no organization in the United States with the mandate to review its safety. For this reason among others, the WHO, Family Health International, and the Institute for Reproductive Health (Department of Obstetrics and Gynecology, Georgetown University) assembled a second internationally recognized panel. The Rockefeller Foundation approved a second Bellagio conference that was held to consider the safety and efficacy of the method. Based on LAM clinical trials and WHO multicenter studies that had confirmed that fully lactating amenorrheic women have about a 1% chance of pregnancy, this panel concluded the following:

“The Bellagio Consensus clearly has been confirmed  … The efficacy of LAM has now been well established in prospective studies, and programs should regard LAM as an additional method that increases the family planning choices for postpartum women. Lactational Amenorrhea Method should receive the programmatic and policy support necessary to become available worldwide … Programs should ensure that any LAM user is able to begin the new method in a manner that ensures continuity of protection from an unplanned pregnancy."57

This new method of family planning has been found to be highly effective (Table 5).

Table 5. Efficacy of the lactational amenorrhea method

Location

Study type

Efficacy: life table analysis, %

Chile57

Prospective study with control group.

99.6

Ecuador58

Retrospective-prospective study of LAM acceptors in a family planning clinic.

98.8

Philippines59

Prospective clinical study among women with previous breastfeeding experience.

99.0

Pakistan60

Prospective clinical study among women with previous breastfeeding experience.

99.4

Rwanda*61

Retrospective-prospective study using client records.

100

Georgetown/WHO/South-to-South multicenter study of LAM62, 63

Prospective study of LAM acceptors in a variety of settings.

98.5

WHO multicenter study of lactational amenorrhea64

Prospective study of lactating amenorrheic women.

99

Multicenter follow-on study*65

Postmarketing study of LAM.

100

LAM use among NFP users66

Prospective study of first menstrual cycle with NFP charting, ultrasound.

100

Egypt67

Passive LAM use.

98.5

Cochrane Review68

Prospective studies.

98.8–99.1

*Significant loss to follow-up.

This new method is now in use in more than 30 countries, and has been included in family planning and maternal and child health policy in several countries.69 Duration of LAM use, which contributes to effectiveness of the method, varied across these studies, averaging about 4–5 months.70 Duration of the method in common usage has been shown to depend on ambient breastfeeding norms and maternal commitment, in addition to physiologic predisposition. LAM may be used no matter what the average breastfeeding pattern may be, as it is a method for individual use, like all other methods. Studies have confirmed that there are a significant minority in nearly every country that could use this method.71

At least one study has shown that LAM provision is associated with a lengthened birth interval.72 However, on average, while LAM use may well be quite important to the individual, it will not have a sufficient impact on birth interval alone to allow women to achieve a healthy interval. Demographic and Health Survey data were used to explore decisions about timing of contraceptive use among postpartum women. The findings revealed that policy and program strategies that focus on counseling immediately postpartum or at a later interval, such as when menses resume, may have a substantial influence on the use of contraceptives.73 The recommendation to switch to another method in a timely manner is best accompanied by counseling for at least 3-year intervals between children.

Studies reveal that the major reasons for non-use of this method include lack of health worker and maternal awareness of the method, belief that there is not sufficient breastfeeding in their population (despite global and national data that show the increasing rates of exclusive breastfeeding), fear of some undesirable effect on health, and concerns about efficacy. Additional reasons for accepting LAM include being convinced by counseling and intention to use LAM initially before switching to another method. One study found that occupation outside the home (P=0.01) and previous knowledge of LAM (P<0.001) emerged as predictors of LAM acceptance.74, 75, 76 These issues are readily addressed with proper information.

LAM has been shown to be efficacious in all settings, even where exclusive breastfeeding may not be the norm. Even in countries such as the US where exclusive breastfeeding may only continue for 2–4 months, the method has an important role. For example, one study found that patterns of exclusive breastfeeding may differ in different settings, e.g. women in Baltimore breastfed less often but for more minutes at each feed than did women in Manila. Nonetheless, the mean durations of lactational amenorrhea were about six months and nine months, respectively, both of adequate duration for LAM use.

Success in the provision of this method is enhanced when there is adequate breastfeeding support available to the mother and when she is properly counseled in those breastfeeding behaviors associated with fertility suppression. Based on the physiologic responses, LAM counseling should include discussion of optimal breastfeeding behaviors for both lactation maintenance and fertility suppression, and the importance of birth spacing and the timely switch to another method of family planning. Studies indicate that the frequency of the breast stimulation and the maintenance of short intervals between feeds (no longer than four hours during the day or six at night) seem to be associated with lactation maintenance.

Advantages and disadvantages of the method include its efficacy and reliability, and that it expands the ‘contraceptive options’ for women. It has been shown to be an effective transition method, encouraging initiation of a longer term method in a timely manner. The method has no additional cost beyond that associated with fully breastfeeding women and it reduces the need for contraceptive commodities needed to achieve adequate birth spacing. The disadvantages of LAM include lack of protection against STIs and that it requires optimal patterns of breastfeeding.58, 77

The term ‘passive LAM use’ is used to describe the situation when the woman has adhered to the criteria but is not actively aware of the method; when the criteria are in place, the efficacy is similar to that found among women actively using the method.78, 79 However, to extend the use of the method, support for six months of exclusive breastfeeding is required, and international guidance recommends six months of exclusive breastfeeding.80, 81 Work by Dewey and colleagues involved a random assignment at four months to continue exclusive breastfeeding, or to begin a high-quality, clean supplement provided free of charge. Two important findings were noted: there was a significant decrease in the breast milk intake and amenorrhea at six months was decreased by 20%.82, 83 Further, exclusive breastfeeding women who do not know about LAM are at risk for not transitioning to another method of contraception at six months postpartum, while women who were aware of LAM criteria were likely to transition appropriately.84 Research in the US found considerable overlap of breastfeeding and contraceptive use; however, many women did not use contraception.85 A study in Egypt found that women of low empowerment index in household decisions were more likely to use passive LAM than modern contraception.86 This may be due to lack of self-efficacy in family planning choices. Clearly, the use of this method, and the practice of optimal breastfeeding in general, are linked to lifestyle choices for the mother.

Infertility

In the diagnosis of infertility, breastfeeding and lactational amenorrhea status should be one of the first aspects of the medical history addressed. Other factors that should be considered include the possibility of subclinical infection associated with secondary infertility, and, where appropriate, extreme altitudes.27, 87 This normal fertility delay may not be welcome among women who wish to plan a subsequent pregnancy and are not concerned with the public health guidance concerning spacing of births.

It is not always necessary to advise cessation of breastfeeding in these cases; adjustment of feeding pattern to favor return of ovulation is a possible alternative. Because hormonal responses are thought to be greater at night, it is suggested that night feedings be limited, and that total 24-hour frequency of breast stimulation be reduced. This should not be recommended unless the infant is independent of the need for breastfeeding for nutrition, health, and immune system development. Lactational infertility may continue even after menses appear to be normal, so counseling should include the possibility of an extended time line, and assurances that optimal maternal nutritional recovery occurs with cessation of breastfeeding when mother and baby decide, followed by about six months of nonlactation, nonpregnant status.

REFERENCES

1

Labbok M. Effects of breastfeeding on the mother. Ped Clin of North America, 2001;48(1):143-5.

2

Horta et al. Evidence on the long-term effects of breastfeeding: systematic reviews and meta-analysis. Available at www.who.int/child-adolescent-health/publications/NUTRITION/ISBN_92_4_159523_0.htm. Accessed June 15, 2008.

3

Ip S et al. Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries, April 2007, Available at www.ahrq.gov/clinic/tp/brfouttp.htm. Accessed June 15, 2008

4

Becker S, Rutstein S, Labbok M. Estimation of births averted due to breastfeeding and increases in levels of contraception needed to substitute for breastfeeding, J Biosoc Sci 2003;35:559-574.

5

Huffman, S. L., and Labbok, M. H. (1994) Breastfeeding in family planning programs: a help or a hindrance? International Journal of Gynaecology and Obstetrics, 47 Suppl, S23-31; discussion S31-2.

6

Kramer MS, Kakuma R. The optimal duration of exclusive breastfeeding: a systematic review. Eur J Contracept Reprod Health Care. 2007 Dec;12(4):335-9

7

WHO/UNICEF. Global strategy for Infant and Young Child Feeding, WHO, Geneva, 2003.

8

CDC NIS Survey, infants born in 2005, at www.cdc.gov/breastfeeding/data/NIS_data/index.htm, accessed August 2008.

9

UNICEF State of the World’s Children 2008

10

Labbok M, Krasovec K: Towards definition of breastfeeding. Stud Fam Plann 21: 226–240, 1990

11

Zinaman MJ, Hughes V, Queenan JT et al: Acute prolactin and oxytocin responses and milk yield to infant suckling and artificial methods of expression in lactating women. Pediatrics 89: 437-440, 1992

12

World Health Organization Global Data Bank on Breastfeeding. Geneva: World Health Organization/United Nations, 1996

13

McNeilly AS: Lactational amenorrhea. Endocrinol Metab Clin North Am 22: 59– 73, 1993

14

McNeilly, A.S. (2001) Lactational control of reproduction. Reproduction, Fertility and Development, 13(7-8), 583-590.

15

McNeilly AS, Tay CC, Glasier A: Physiological mechanisms underlying lactational amenorrhea. Ann NY Acad Sci 709: 145–155, 1994

16

Cox D, Owens R, and P Hartmann. Blood and milk. Prolactin and the rate of milk synthesis in women. Exper Physiol. 1996. 81, 1007-1020.

17

Diaz S, Seron-Ferre M, Croxatto HB et al: Neuroendocrine mechanisms of lactational infertility in women. Biol Res 28: 155–163, 1995

18

Nunley WC, Urban RJ, Evans WS et al: Preservation of pulsatile luteinizing hormone release during postpartum lactational amenorrhea. J Clin Endocrinol Metab 73: 629– 636, 1991

19

Zinaman M, Cartledge T, Tomai T et al: Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women. J Clin Endocrinol Metab 80: 2088–2093, 1995

20

Kremer JA, Borm G, Schellekens LA et al: Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone. J Clin Endocrinol Metab 72: 294–00, 1991

21

Tay CC, Glasier AF, McNeilly AS: Twenty-four hour patterns of prolactin secretion during lactation and the relationship to suckling and the resumption of fertility in breast-feeding women. Hum Reprod 11: 950–955, 1996

22

Diaz, S., Aravena, R., Cardenas, H., Casado, M.E., Miranda, P., Schiappacasse, V., et al. (1991) Contraceptive efficacy of lactational amenorrhea in urban Chilean women. Contraception, 43(4), 335-352.

23

Simondon KB, Delaunay V, Diallo A, Elguero E, Simondon F. Lactational amenorrhea is associated with child age at the time of introduction of complementary food: a prospective cohort study in rural Senegal, West Africa. Am J Clin Nutr. 2003 Jul;78(1):154-61.

24

Diaz S, Cardenas H, Brandeis A et al: Early difference in the endocrine profile of long and short lactational amenorrhea. J Clin Endocrinol Metab 72: 196–201, 1991

25

Kurz K, Habicht JP, Rasmussen KM et al: Effects of maternal nutritional status and maternal energy supplementation on length of postpartum amenorrhea among Guatemalan women. Am J Clin Nutr 58: 636–642, 1993

26

Wasalathanthri S, Tennekoon KH.Lactational amenorrhea/anovulation and some of their determinants: a comparison of well-nourished and undernourished women. Fertil Steril. 2001 Aug;76(2):317-25

27

Neville M: Physiology of lactation. Clin Perinatal 26: 251–279, 1999

28

Rasmussen KM. Association of maternal obesity before conception with poor lactation performance. Annu Rev Nutr. 2007;27:103-21.

29

WHO Task Force on Methods for the Natural Regulation of Fertility: The WHO Multinational Study of Breast-feeding and Lactational Amenorrhea: I. Description of infant feeding patterns and of the return of menses. Fertil Steril 70:448–460, 1998

30

WHO Task Force on Methods for the Natural Regulation of Fertility. The WHO Multinational Study of Breast-feeding and Lactational Amenorrhea: II. Factors associated with the length of amenorrhea Fertil Steril 70:461–471, 1998

31

Gray R, Apelo R, Campbell O et al: The return of ovarian function during lactation: results of studies from the U.S. and the Philippines. In Gray R (ed): Biomedical and Demographic Determinants of Reproduction, pp 428–445. Oxford: Colorado Press, 1993

32

Diaz S, Cardenas H, Brandeis A et al: Relative contributions of anovulation and luteal phase defect to the reduced pregnancy rate of breastfeeding women. Fertil Steril September 58: 498–503, 1992

33

WHO Task Force on Methods for the Natural Regulation of Fertility. The WHO Multinational Study of Breast-feeding and Lactational Amenorrhea: IV. Postpartum bleeding and lochia in breastfeeding women. 72:441–447, 1999

34

Perez A, Vela P, Masnick GS et al: First ovulation after childbirth: The effect of breastfeeding. Am J Obstet Gynecol 114: 1041–1047, 1972

35

Prieto CR, Cardena H, Croxatto HB: Variability of breast sucking, associated milk transfer and the duration of lactational amenorrhea. J Reprod Fertil 115: 193–200, 1999

36

Kaitz M, Good A, Rohem AM et al: Mother's recognition of the newborns by olfactory cues. Dev Psychobiol 20: 587–591, 1987

37

Zhu BP, Rolfs RT, Nangle BE et al: Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med 25;340:589–594, 1999

38

Klerman LV, Cliver SP, Goldenberg RL: The impact of short interpregnancy intervals on pregnancy outcomes in a low-income population. Am J Public Health 88: 1182–1185, 1998

39

Rutstein S: Morbidity and mortality outcomes associated with duration of inter-birth intervals. Unpublished analyses of Demographic and Health Surveys, MACRO, International, March 2000

40

Farr G, Rivers R: Interactions between intrauterine contraceptive device use and breastfeeding status at time of insertion: analysis of Tcu-380A acceptors in developing countries. Am J Obstet Gynecol 167: 144, 1992

41

Nilsson S, Nygren K: Transfer of contraceptive steroids to human milk. Res Reprod 11: 1, 1979

42

Shaaban M, Salem H, Abdullah K: Influence of levonorgestrel contraceptive implants (Norplant) initiated early postpartum upon lactation and infant growth. Contraception 32: 623, 1985

43

Shaaban M, Olind V, Salem H et al. Levonorgestrel concentration in maternal and infant serum during use of subnormal levonorgestrel contraceptive implant, Norplant, by nursing mothers. Contraception 1986, 33:357

44

Massai R, Quinteros E, Reyes MV, Caviedes R, Zepeda A, Montero JC, Croxatto HBExtended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial. Contraception. 2005 Nov;72(5):352-7. Epub 2005 Jun 29

45

Hatcher R, Trussell J, Nelson A, et al: Contraceptive Technology, Ardent Media, Inc. 2007, pp 407-409, 759.

46

Diaz S, Zepeda A, Maturana X et al: Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and copper T 380-A intrauterine devices. Contraception 56: 223–232, 1997

47

Diaz S, Reyes MV, Zepeda A et al: Norplant implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning. Hum Reprod 14: 2499–2505, 1999

48

Dorea JG, Myazaki ES: Calcium and phosphorus in milk of Brazilian mothers using oral contraceptives. J Am Coll Nutr 17: 642–646, 1998

49

Dorea JG, Myazaki ES: The effects of oral contraceptive use on iron and copper concentrations in breast milk. Fertil Steril 72: 297–301, 1999

50

Visness CM, Rivera R: Progestin-only pill use and pill switching during breastfeeding. Contraception 51: 279–281, 1995

51

Labbok M, Nichols-Johnson V, Valdes-Anderson V. ABM Clinical Protocol #13: Contraception during breastfeeding, Breastfeeding Medicine 2006;1(1):43-51. Updates will be available at intervals at www.bfmed.org/index.asp?menuID=139&firstlevelmenuID=139

52

Tyson JE, Perez, Zanartu J: Human lactational response to oral thyrotropin releasing hormone. J Clin Endocrinol Metab 43: 760–768, 1976

53

Tyson JE, Freedman RS, Perez A et al: Significance of the secretion of human prolactin and gonadotrophin for puerperal lactational infertility. Ciba Found Symp:49–71, 1976

54

Vega RR, Barraza-Vazquez A, Vega MG et al: GnRH agonist for postpartum contraception: Biochemical, hormonal and endometrial effects. Adv Contracept 12: 15–25, 1996

55

Kennedy K, Rivera R, McNeilly A: Consensus statement on the use of breastfeeding as a family planning method. Contraception 39: 477–496, 1989

56

Labbok M, Cooney K, Coly S: Guidelines: Breastfeeding, Family Planning, and the Lactational Amenorrhea Method (LAM). 2nd ed. Washington, DC: Institute for Reproductive Health, 1994

57

Perez A, Labbok M, Queenan J: Clinical study of the lactational amenorrhea method for family planning. Lancet 339: 968, 1992

58

Labbok M, Perez A, Valdes V et al: The lactational amenorrhea method: A new postpartum introductory family planning method with program and policy implications. Adv Contracept 10: 93– 109, 1994

59

Ramos R, Kennedy KI, Visness CM: Effectiveness of lactational amenorrhoea in prevention of pregnancy in Manila, the Philippines: Noncomparative prospective trail. BMJ 12;313:909–912, 1996

60

Kazi A, Kennedy K, Visness CM et al: Effectiveness of the lactational amenorrhea method in Pakistan. Fertil Steril 64: 717–723, 1995

61

Cooney K, Labbok M et al. An assessment of the nine-month lactational amenorrhea method (MAMA-9) in Rwanda. Stud Fam Plann 27:102–171, 1996

62

Labbok M, Hight-Laukaran V, Peterson A et al: Multicenter study of the lactational amenorrhea method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception 55: 327–336, 1997

63

Hight-Laukaran V, Labbok M, Peterson A et al: Multicenter study of the lactational amenorrhea method (LAM): II. Acceptability, utility, and policy implications. Contraception 55: 337–346, 1997

64

WHO Task Force on Methods for the Natural Regulation of Fertility: The WHO Multinational Study of Breast-feeding and Lactational Amenorrhea. III. Pregnancy during breastfeeding. Fertil Steril 72:431–440, 1999

65

Peterson A, Labbok M, Hight-L V et al: Multicenter study of the lactational amenorrhea method (LAM): III. “Post-marketing” study with limited clinical contact. Contraception 162: 62, 1999

66

Tommaselli G.A., Guida M., Palomba S., Barbato M., and Nappi, C. (2000) Using complete breastfeeding and lactational amenorrhoea as birth spacing methods. Contraception, 61(4), 253-257.

67

Shaaban, O.M., and Glasier, A.F. (2008) Pregnancy during breastfeeding in rural Egypt. Contraception, 77(2008), 350-354.

68

Van der Wijden, C., Kleijnen, J., and Van Den Berk, T. (2008) Lactational amenorrhea for family planning. Cochrane Database System Review, Issue 4. Art. No.: CD001329. DOI: 10.1002/14651858.CD001329.

69

Vekemans M: Postpartum contraception: the lactational amenorrhea method, Eur J Contracept Reprod Health Care 2:105–111, 1997

70

Romero-Gutiérrez G, Vaca-Ortiz N, Ponce-Ponce de León AL, López-Martínez MG.Actual use of the lactational amenorrhoea method.Eur J Contracept Reprod Health Care. 2007 Dec;12(4):340-4.

71

Zhang, L. Y., Liu, Y. R., Shah, I. H., Tian, K. W., and Zhang, L. H. (2002) Breastfeeding, amenorrhea and contraceptive practice among postpartum women in Zibo, China. European Journal of Contraception and Reproductive Health Care, 7(3), 121–126.

72

Hardy D, Santos LC, Osis MJ et al: Contraceptive use and pregnancy before and after introducing lactational amenorrhea (LAM) in a postpartum program. Adv Contraception 14: 59– 68, 1998

73

Hight-Laukaran, V., Rutstein, S. O., Labbok, M. H., and Ballard, E. (1996) Contraceptive use during lactational amenorrhea. International Journal of Gynaecology and Obstetrics, 54(2), 101–108.

74

Lopez-Martinez M, Romero-Gutierrez G, Ponce-Ponce De Leon A. (2006.)Acceptance of lactational amenorrhoea for family planning after postpartum counseling. The European Journal of Contraception and Reproductive Health Care, 11(4), 297-301.

75

Vural, B., Vural, F., Erk, A., and Karabacak, O. (1999) Knowledge of lactational amenorrhea and contraception in Kocaeli, Turkey. East African Medical Journal, 76(7), 385–389.

76

Khella, A. K., Fahim, H. I., Issa, A. H., Sokal, D. C., and Gadalla, M. A. (2004) Lactational amenorrhea as a method of family planning in Egypt. Contraception, 69(4), 317–222.

77

Kennedy, K.I., Kotelchuck, M. (1998) Policy considerations for the introduction and promotion of the lactational amenorrhea method: Advantages and disadvantages of LAM. Journal of Human Lactation, 14 (3), 191-203.

78

Kennedy, K.I., Kotelchuck, M., Visness, C.M., Kazi, A., & Ramos, R. (1998.) Users’ understanding of the lactational amenorrhea method and the occurrence of pregnancy. Journal of Human Lactation, 14 (3), 209-218.

79

Van der Wijden C, Kliejnen J, Ven Den Berk T. Lactational amenorrhea for family planning. Cochrane Database System Review, issue 4. Art. No. CD001329, 2008.

80

American Academy of Pediatrics Statement on Breastfeeding, 1999

81

WHO/UNICEF. Global Strategy for Infant and Young Child Feeding. WHO, Geneva, 2003.

82

Cohen R, Brown KH, Canahuati J et al: Effects of age of introduction of complementary foods on infant breast milk intake, total energy intake, and growth: a randomised intervention study in Honduras. Lancet 344: 288–293, 1994

83

Dewey KG, Cohen RJ, Rivera LL et al: Effects of age at introduction of complementary foods to breast-fed infants on duration of lactational amenorrhea in Honduran women. Am J Clin Nutr 65: 1403–1409, 1997

84

Bongiovanni, A., Samam’h, M.A., Al’Sarabi, R.H., Masri, S.D., Zehner, E.R., and Huffman, S.L. (2005) Promoting the Lactational Amenorrhea Method (LAM) in Jordan increases modern contraception use in the extended postpartum period. The Linkages Project. Washington, DC: Academy for Educational Development. www.linkagesproject.org/media/publications/LAM%20Research%20Report,%20Final, %20November%201,%202005.pdf

85

Ford K, Labbok M: Breast-feeding and child health in the United States. J Biosoc Sci 25: 187–194, 1993

86

Afifi, M. (2007) Lactational amenorrhoea method for family planning and women empowerment in Egypt. Singapore Medical Journal, 48(8), 758-762.

87

Wiley AS: The ecology of low natural fertility in Ladakh. J Biosoc Sci 30: 457–480, 1998